Edition:
United Kingdom

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

20.48USD
25 Apr 2018
Change (% chg)

$0.23 (+1.14%)
Prev Close
$20.25
Open
$20.15
Day's High
$20.95
Day's Low
$20.15
Volume
14,196
Avg. Vol
27,963
52-wk High
$24.00
52-wk Low
$15.01

Chart for

About

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)

Overall

No Ratios Available.

Financials

  OPTN.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -- -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Optinose Announces $100 Mln Debt Financing From Athyrium Capital Management

* OPTINOSE ANNOUNCES $100 MILLION DEBT FINANCING FROM ATHYRIUM CAPITAL MANAGEMENT Source text for Eikon: Further company coverage:

02 Jan 2018

BRIEF-OptiNose Inc Qtrly Net Loss ‍$4.23 Per Share​

* OPTINOSE INC - QTRLY NET LOSS ‍$4.23 PER SHARE​ Source text for Eikon: (http://bit.ly/2BiwpZA) Further company coverage:

27 Nov 2017

Earnings vs. Estimates